ReproNovo
PrivateLast Round
Series A
May 21, 2025
Total Funding Raised
$65M
Company Overview
ReproNovo is a biopharmaceutical company that develops innovative treatments for reproductive medicine and women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReproNovo Comparables
Compare ReproNovo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivalyx | 84% | |
| Bridge to Life | 84% | |
| Organ Recovery Systems | 79% | |
ReproNovo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 21, 2025 |
Key People
Founding team and executive leadership
ReproNovo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ALSA Ventures | Series A |
| M Ventures | Series A, Seed |
| Ysios Capital | Series A |
| AXA IM Alts | Series A |
| BNP Paribas Asset Management | Series A |
| Jeito Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 291% MoM, reaching 1.6K.
- May 21, 2025
$65M Series A round completed.
ReproNovo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ReproNovo's valuation, stock price, and market status.